Shuichi Okada
Publication Activity (10 Years)
Years Active: 2019-2023
Publications (10 Years): 9
Publications (10 Years): 9
Publications
- Ryota Uehara, Eijiro Yamada, Shuichi Okada, Claire C Bastie, Akito Maeshima, Hidekazu Ikeuchi, Kazuhiko Horiguchi, Masanobu Yamada
- Ryota Uehara, Eijiro Yamada, Shuichi Okada, Claire C Bastie, Akito Maeshima, Hidekazu Ikeuchi, Kazuhiko Horiguchi, Masanobu Yamada
- Ryota Uehara, Eijiro Yamada, Shuichi Okada, Claire C Bastie, Akito Maeshima, Hidekazu Ikeuchi, Kazuhiko Horiguchi, Masanobu Yamada
- Ryota Uehara, Eijiro Yamada, Yasuyo Nakajima, Aya Osaki, Shuichi Okada, Masanobu Yamada
- Junichi Okada, Noriaki Sunaga, Eijiro Yamada, Tsugumichi Saito, Atsushi Ozawa, Yasuyo Nakajima, Kazuya Okada, Jeffrey E Pessin, Shuichi Okada, Masanobu Yamada
- Takuya Watanabe, Atsushi Ozawa, Shinnosuke Masuda, Satoshi Yoshino, Emi Ishida, Yuri Kondo, Shunichi Matsumoto, Akiko Katano-Toki, Kazuhiko Horiguchi, Yasuyo Nakajima, Eijiro Yamada, Takuya Tomaru, Tsugumichi Saito, Sumiyasu Ishii, Nobuyuki Shibusawa, Shuichi Okada, Tetsurou Satoh, Masanobu Yamada
- Junichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, Masanobu Yamada
- Junichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, Masanobu Yamada
- Aya Osaki, Yoko Shimoda, Junichi Okada, Eijiro Yamada, Tsugumichi Saito, Yasuyo Nakajima, Atsushi Ozawa, Yawara Niijima, Shuichi Okada, Masanobu YamadaLower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (4) (2019)